The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...

Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival ...

Related: ShopMy's New Consumer Shopping Platform Prioritizes Human Recommendations Over Algorithms Related: See the Official ...

More than a 25 percent came off the drugs due to gut problems or mental health effects, Half regained weight after stopping.

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

EXCLUSIVE: Claire Reid began using weight loss injections in March after seeing others have success using them.

People taking weight loss drugs typically start to lose weight within a few weeks. One study, funded by Mounjaro manufacturer ...

According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

People regularly exposed to ‘forever chemicals’ are at greater risk of developing type 2 diabetes compared to those rarely ...

An alarming increase in chronic illness—particularly cancer, diabetes, and hypertension—is driving health insurance costs ...

Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under ...